Phenotype measures set:   Wiltshire3   GFAP

ID, description, units MPD:38128   GFAP   cerebral cortex GFAP, relative fluorescence intensity  
fluoxetine study
Measures • control    • fluoxetine    • change index
Data set, strains Wiltshire3   inbred   30 strains     sex: m     age: 10-11wks
Procedure biomarker quantification
Comparisoncontrol group vs. treated group
Availability note:Individual animal data were not submitted. Some functionality not available.
Ontology mappings



Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

Wiltshire3 - cerebral cortex GFAP, relative fluorescence intensity


Female

Male





  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire3 38128 biomarker quantification fluoxetine cerebral cortex GFAP, relative fluorescence intensity   control   GFAP_cont inbred 30 m 10-11wks
Wiltshire3 38129 biomarker quantification fluoxetine cerebral cortex GFAP, relative fluorescence intensity   fluoxetine   GFAP_fluox inbred 30 m 10-11wks
Wiltshire3 38130 biomarker quantification fluoxetine cerebral cortex GFAP, relative fluorescence intensity   change index   GFAP_index inbred 30 m 10-11wks (not included in plot or analytics)